Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Principles of Drug Action01:24

Principles of Drug Action

7.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gli2-serpinh1 drives fibroblast state transition during skin wound healing.

NPJ Regenerative medicine·2026
Same author

Amplifying bacterial cuproptosis by NIR driven biomimetic metal organic framework for nanocatalytic enhanced bacterial pneumonia immunotherapy.

Bioactive materials·2026
Same author

Comparison of XEN gel stent for management of open-angle glaucoma: a systematic review and meta-analysis.

PeerJ·2026
Same author

Azidothymidine potentiates the immunomodulatory function of interferon-α in adult T cell leukemia/lymphoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

The m<sup>6</sup>A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA.

Journal of virology·2026
Same author

A metal-organic framework-based trilayer biomimetic coating on lacrimal stents for dual-drug therapy to prevent restenosis.

Acta biomaterialia·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K

Artificial intelligence and big data facilitated targeted drug discovery.

Benquan Liu1, Huiqin He1, Hongyi Luo1

  • 1Jiangsu Key Lab of Drug Screening, China Pharmaceutical University, Nanjing, China.

Stroke and Vascular Neurology
|February 8, 2020
PubMed
Summary

This review explores advanced methods integrating big biological data from databases like TCGA and DrugBank with artificial intelligence (AI) for novel drug discovery. The focus is on identifying effective lead compounds with favorable ADMET properties.

Keywords:
artificial intelligencebig datatargeted drug

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.5K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Drug Discovery

Background:

  • Publicly available biological databases (e.g., Cancer Genome Atlas, DrugBank, PubChem, Protein Data Bank) offer vast multidisciplinary big data.
  • Artificial intelligence (AI) is increasingly crucial in accelerating drug discovery processes.

Purpose of the Study:

  • To review advanced methods for discovering highly effective lead compounds.
  • To highlight the integration of big biological data and AI in drug discovery.

Main Methods:

  • Leveraging diverse biological databases for comprehensive data.
  • Applying artificial intelligence algorithms for data analysis and prediction.
  • Focusing on lead compound identification with desirable ADMET properties.

Main Results:

  • Integration of big data and AI significantly impacts novel targeted drug discovery.
  • Advanced methods enable the identification of compounds with optimized absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles.

Conclusions:

  • The synergy between big biological data and AI presents a powerful approach for discovering novel therapeutics.
  • Further development of these integrated methods promises to enhance the efficiency and success rate of drug discovery.